Association of the metabolic syndrome with intracranial atherosclerotic stroke

Oh Young Bang; J. W. Kim; J. H. Lee; M. A. Lee; P. H. Lee; I. S. Joo; K. Huh

doi:10.1212/01.wnl.0000168862.09764.9f

Association of the metabolic syndrome with intracranial atherosclerotic stroke

Oh Young Bang, J. W. Kim, J. H. Lee, M. A. Lee, P. H. Lee, I. S. Joo, K. Huh

Department of Neurology

Research output: Contribution to journal › Article › peer-review

124 Citations (Scopus)

Abstract

To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

Original language	English
Pages (from-to)	296-298
Number of pages	3
Journal	Neurology
Volume	65
Issue number	2
DOIs	https://doi.org/10.1212/01.wnl.0000168862.09764.9f
Publication status	Published - 2005 Jul 26

Bibliographical note

Funding Information:
Supported by Korea Research Foundation grant KRF-2003-E00228.

All Science Journal Classification (ASJC) codes

Clinical Neurology

Access to Document

10.1212/01.wnl.0000168862.09764.9f

Cite this

@article{2b890807d4594cccabf6d9e9bf02d718,

title = "Association of the metabolic syndrome with intracranial atherosclerotic stroke",

abstract = "To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.",

author = "Bang, {Oh Young} and Kim, {J. W.} and Lee, {J. H.} and Lee, {M. A.} and Lee, {P. H.} and Joo, {I. S.} and K. Huh",

note = "Funding Information: Supported by Korea Research Foundation grant KRF-2003-E00228. ",

year = "2005",

month = jul,

day = "26",

doi = "10.1212/01.wnl.0000168862.09764.9f",

language = "English",

volume = "65",

pages = "296--298",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Association of the metabolic syndrome with intracranial atherosclerotic stroke

AU - Bang, Oh Young

AU - Kim, J. W.

AU - Lee, J. H.

AU - Lee, M. A.

AU - Lee, P. H.

AU - Joo, I. S.

AU - Huh, K.

N1 - Funding Information: Supported by Korea Research Foundation grant KRF-2003-E00228.

PY - 2005/7/26

Y1 - 2005/7/26

N2 - To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

AB - To investigate the impact of metabolic syndrome (MetSD) on the development of intracranial atherosclerotic stroke, the authors evaluated the components of the MetSD in 512 patients with stroke. The MetSD was observed most frequently in patients with intracranial atherosclerosis (p = 0.007). In multiple regression analysis, the MetSD, but not conventional risk factors, was independently associated with intracranial atherosclerosis (p = 0.005). The results suggest that treatment of metabolic abnormalities may be an important prevention strategy for intracranial atherosclerosis.

UR - http://www.scopus.com/inward/record.url?scp=22544450816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22544450816&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000168862.09764.9f

DO - 10.1212/01.wnl.0000168862.09764.9f

M3 - Article

C2 - 16043803

AN - SCOPUS:22544450816

SN - 0028-3878

VL - 65

SP - 296

EP - 298

JO - Neurology

JF - Neurology

IS - 2

ER -

Association of the metabolic syndrome with intracranial atherosclerotic stroke

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this